Confidential Project

Project Emerald

Late-stage pharmaceutical company advancing Bivante, a DMA-free IV busulfan formulation for stem cell transplant conditioning, on a defined 505(b)(2) regulatory path.

Download Project Emerald ↓

Industry

Pharma / Biotech

Headquarters

Houston, TX

Market

>$300M annual

Capital Sought

$5.0mm Series B

Project Emerald — Investment Teaser Open in New Tab ↗ Download ↓

Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.

Strictly confidential · Prepared by Intelligentzia Capital Management · Scroll within the frame to navigate pages

Discuss This Project

Explore Project Emerald